Candel Therapeutics, Inc.CADLNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P13
Within normal range
vs 3Y Ago
-2.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -19.27% |
| Q3 2025 | -18.16% |
| Q2 2025 | -37.48% |
| Q1 2025 | 0.14% |
| Q4 2024 | 7.03% |
| Q3 2024 | -2.17% |
| Q2 2024 | -8.47% |
| Q1 2024 | 23.42% |
| Q4 2023 | -16.44% |
| Q3 2023 | 7.50% |
| Q2 2023 | 0.56% |
| Q1 2023 | -18.91% |
| Q4 2022 | 8.78% |
| Q3 2022 | -1.46% |
| Q2 2022 | 2.59% |
| Q1 2022 | -16.10% |
| Q4 2021 | 3.60% |
| Q3 2021 | -51.46% |
| Q2 2021 | -13.83% |
| Q1 2021 | 23.97% |
| Q4 2020 | -122.81% |
| Q3 2020 | -4.96% |
| Q2 2020 | -12.99% |
| Q1 2020 | 0.00% |